These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7501500)

  • 21. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced extrapyramidal movement disorders of the face and jaw in dyskinesia.
    Pfau FR
    N C Dent J; 1976; 59(1):20-2. PubMed ID: 25393
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.
    Werge T; Elbaek Z; Andersen MB; Lundbaek JA; Rasmussen HB
    Pharmacogenomics J; 2003; 3(2):97-100. PubMed ID: 12746734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Movement disorders induced by neuroleptic therapy].
    Almeida R; Santos MV
    Acta Med Port; 1993 Jun; 6(6):239-44. PubMed ID: 8103618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does 'selective binding profile' result in 'selective treatment'?].
    Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):1-5. PubMed ID: 11400320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atypical antipsychotics in the elderly].
    van Melick EJ;
    Tijdschr Gerontol Geriatr; 2004 Dec; 35(6):240-5. PubMed ID: 15704604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pipotiazine palmitate, a long acting drug, indeed: a case report.
    Hyrman V
    Can J Psychiatry; 1985 Apr; 30(3):221-2. PubMed ID: 2859922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory dyskinesia. An underrecognized phenomenon.
    Rich MW; Radwany SM
    Chest; 1994 Jun; 105(6):1826-32. PubMed ID: 7911419
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescribing phenothiazines.
    Med J Aust; 1977 Apr; 1(14):504-6. PubMed ID: 17053
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenothiazine induced dyskinesia in children.
    Goel R; Misra PK
    Indian Pediatr; 1981 Mar; 18(3):203-7. PubMed ID: 7263024
    [No Abstract]   [Full Text] [Related]  

  • 36. TMJ dysfunction.
    Bhuva K; Matthews W; Carter LM; Kanatas A
    Br Dent J; 2012 Aug; 213(4):145. PubMed ID: 22918324
    [No Abstract]   [Full Text] [Related]  

  • 37. An effective palliative treatment for phenothiazine-induced tardive dyskinesia.
    Betts WC; Johnston FS; Pratt MJ
    N C Med J; 1979 May; 40(5):286. PubMed ID: 86958
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacological experience with phenothiazines and butyrophenones].
    Cuisset P; Roujas F
    Ann Anesthesiol Fr; 1976; 17(9):1025-32. PubMed ID: 13687
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Side effects of phenothiazines.
    Vanĕcek J; Fink Z
    Act Nerv Super (Praha); 1975; 17(4):220-1. PubMed ID: 3933
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse effects of neurolepitcs from the biochemical viewpoint].
    Kluge H; Hartmann W; Wieczorek V
    Z Arztl Fortbild (Jena); 1974 Nov; 68(22):1207-9. PubMed ID: 4156445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.